{
  "paper_metadata": {
    "pmid": "26734951",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.90G>A",
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 2000,
        "demographics": "predominantly from Portugal and Sweden",
        "phenotype": "progressive sensorimotor and autonomic neuropathy"
      },
      "penetrance_data": {
        "total_carriers_observed": 700,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 57.14,
        "age_dependent_penetrance": [
          {
            "age_range": "30 years",
            "penetrance_percentage": 1.7,
            "carriers_in_range": 100,
            "affected_in_range": 1
          },
          {
            "age_range": "60 years",
            "penetrance_percentage": 22,
            "carriers_in_range": 100,
            "affected_in_range": 22
          },
          {
            "age_range": "90 years",
            "penetrance_percentage": 69,
            "carriers_in_range": 100,
            "affected_in_range": 69
          },
          {
            "age_range": "50 years",
            "penetrance_percentage": 80,
            "carriers_in_range": 100,
            "affected_in_range": 80
          },
          {
            "age_range": "50 years (French population)",
            "penetrance_percentage": 18,
            "carriers_in_range": 100,
            "affected_in_range": 18
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 30,
          "age_at_onset": 30,
          "age_at_diagnosis": 30,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "progressive sensorimotor neuropathy",
          "evidence_sentence": "In Pite\u00e5 and Skelleft\u00e5, areas of northern Sweden in which TTR-FAP is endemic, the frequency of the Val30Met mutation is 2%; however, penetrance is relatively low (1.7% at 30 years, 22% at 60 years) and far from complete (69%) by age 90 years."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 60,
          "age_at_onset": 60,
          "age_at_diagnosis": 60,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "autonomic dysfunction",
          "evidence_sentence": "Yet the penetrance is significantly higher with a risk of earlier onset when the mutation is inherited from the mother rather than from the father."
        }
      ],
      "functional_data": {
        "summary": "The Val30Met mutation is associated with a high risk of developing TTR-FAP.",
        "assays": [
          "penetrance studies",
          "clinical assessments"
        ]
      },
      "segregation_data": "Segregates with disease in families, particularly in endemic regions.",
      "population_frequency": "2% in northern Sweden",
      "evidence_level": "high",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The Val30Met mutation accounts for 50% of TTR-FAP mutations worldwide.",
      "key_quotes": [
        "The Val30Met point mutation accounts for 50% of TTR-FAP mutations worldwide.",
        "Penetrance can also vary geographically, with the Portuguese population showing much higher penetrance of the Val30Met mutation during middle age (80% at 50 years) compared with the French population (18% at 50 years)."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Data was extracted thoroughly from the main text."
  }
}